Procalcitonin is a promising marker for identification of bacterial infections. The accuracy and clinical value of procalcitonin for
diagnosis of sepsis in critically ill patients was assessed in this meta-analysis.
Medline, Embase, ISI Web of Knowledge, the Cochrane Library, Scopus, BioMed Central, and Science Direct were searched, from inception to Feb 21, 2012,
and reference lists of identified primary studies. We included articles written in English, German, or French that investigated procalcitonin
for differentiation of septic patients--those with sepsis, severe sepsis, or septic shock--from those with a systemic inflammatory response syndrome of
non-infectious origin. Studies of healthy people, patients without probable infection, and children younger than 28 days were excluded.
Two independent investigators extracted patient and study characteristics; discrepancies were resolved by consensus.
This search returned 3487 reports, of which 30 fulfilled the inclusion criteria, accounting for 3244 patients.